Composition for preventing and treating bone arthritis and application thereof

Abstract

The invention provides a composition for preventing and treating bone arthritis. The composition is characterized by comprising non-denaturing type II collagen and cartilage collagen peptide accordingto a weight ratio of 1:(0.5 to 30), preferably 1:(1 to 20), more preferably 1:(1.5 to 10), and most preferably 1:(1.5 to 6). The invention also provides application of the composition in preparationof a product for preventing and treating the bone arthritis, wherein the product is a medicine or health-care food. The composition for preventing and treating bone arthritis has the advantages that the cartilage collagen peptide can be used as a raw material needed for synthesizing cartilage tissues, the degradation of joints is prevented, and the repair function is realized on the injured joints; the non-denaturing type II collagen can inhibit the generation of inflammation, so as to relieve and treat the arthritis; proved by experiment results, the combination of the cartilage collagen peptide and the non-denaturing type II collagen can achieve a synergistic effect on the preventing and treatment of arthritis.

Description

technical field [0001] The invention relates to a composition for preventing and treating osteoarthritis and its application, in particular to a composition containing non-denatured type II collagen and cartilage collagen peptide and its application. Background technique [0002] In the past 20 years, the incidence of joint diseases in my country has been increasing, and osteoarthritis is the most common joint disease. At present, more than half of the elderly over 60 years old in my country suffer from osteoarthritis. At the same time, osteoarthritis caused by young people's improper exercise and trauma is becoming more and more common, and osteoarthritis has shown a trend of younger age. In fact, the disability rate of osteoarthritis can be as high as 53%, and the severity of pain and dysfunction caused by osteoarthritis is comparable or even greater than that of cardiovascular and cerebrovascular diseases. [0003] Articular cartilage is mainly composed of collagen (59%...

AI Technical Summary

Problems solved by technology

However, with the increase of age, the synthesis rate of collagen gradually decreases, the loss of collagen increases, and the network structure relaxes or even breaks, which accelerates the loss of proteoglycan and other components, degeneration of articular cartilage, and intensified friction between bones , causing inflammation in the joints

[0004] The drugs currently used for osteoarthritis are mainly non-steroidal anti-inflammatory drugs, which have anti-inflammatory and analgesic effects, and are suitable for inflammatory pain; however, these drugs can cause nausea, vomiting and other gastrointestinal discomfort, and long-term use will also increase digestion. risk of tract bleeding

Moreover, such traditional treatment methods such as detumescence and pain relief can only treat the symptoms, but are difficult to cure the root cause.

[0005] The products for osteoarthritis appearing in the health care products market are mainly glucosamine and chondroitin sulfate. These health products have a certain degree of nutritional supplement effect, but the effect is also very limited; moreover, because these health products do not have anti-inflammatory effects , in order to relieve pain caused by inflammation, additional anti-inflammatory drugs are required

[0006] At present, there is still a lack of effective food or medicine for the prevention and treatment of osteoarthritis